← Back to Treatments
🏅 FDA Orphan Designation

Cetylev

acetylcysteine effervescent tablets for oral solution

Manufacturer: Arbor Pharmaceuticals, Inc.

Indicated for:
NON RARE IN EUROPE: Peyronie syndromeOrphanParacetamol poisoning

FDA-Approved Indications (2)

Indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion

Indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion

Population: all ages

Indications & Usage

Indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion

💙 Support Programs

View all →
Cetylev
Arbor Pharmaceuticals, Inc.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.